“…The metabolic processes that inactivate bioactive BRs include dehydrogenation at C-3 and C-23 (Hai et al, 1996;Watanabe et al, 2000), epimerization at C-2, C-3, and C-24 (Suzuki et al, 1993;Nishikawa et al, 1995), hydroxylation at C-20, C-25, and C-26 (Voigt et al, 1993;Kolbe et al, 1996;Yokota et al, 1996), side chain cleavage at C-20/22 (Kolbe et al, 1996), and sulfonation at C-22 (Rouleau et al, 1999). In addition, active BRs are inactivated through conjugation by esterification at C-3 (Kolbe et al, 1995;Asakawa et al, 1996) and glycosylation at C-2, C-3, C-23, C-25, and C-26 (Bajguz, 2007).…”